Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Dispenzieri

Showing results (721-730 of 759) with videos related to

Pageof 76
Sort By:
Blood Advances|April 14, 2026
Diagnostic Utility of Immunofixation and Free Light Chain Assay in AL Amyloidosis: A Systematic Review and Meta-analysisMuayad Azzam, Qais Hamarsha, Hassan Kawtharany, et al.
Blood Advances|April 9, 2026
Determinants of Gastrointestinal Disease Burden and Survival in Systemic AL AmyloidosisMaximilian Johannes Steinhardt, Eli Muchtar, Taxiarchis V Kourelis, et al.
Blood Cancer Journal|June 23, 2026
Characteristics and outcomes of secondary hematological malignancies following autologous stem cell transplantation for multiple myelomaBinoy Yohannan, Benjamin W Langworthy, Lindsey E Turner, et al.
Blood|July 8, 2017
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed lenalidomide-refractory multiple myelomaJonas Paludo, Joseph R Mikhael, Betsy R LaPlant, et al.
American Journal of Hematology|January 11, 2021
Comparison of the current renal staging, progression and response criteria to predict renal survival in AL amyloidosis using a Mayo cohortMaria Eleni Drosou, Lisa E Vaughan, Eli Muchtar, et al.
Haematologica|March 5, 2026
Real-world outcomes of newly diagnosed multiple myeloma patients treated with front-line daratumumab bortezomib lenalidomide and dexamethasoneRicardo D Parrondo, Ricardo De Menezes, Hanna Sledge, et al.
Clinical Transplantation|January 8, 2025
Amyloidosis and Heart Transplantation in a New EraMelissa A Lyle, Juan Maria M Farina, Erin Wiedmeier-Nutor, et al.
Mayo Clinic Proceedings|April 2, 2013
Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013Joseph R Mikhael, David Dingli, Vivek Roy, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 1, 2026
The role of cardiac imaging for diagnosis of cardiac amyloidosis: a systematic review and meta-analysis of test accuracyHassan Kawtharany, Muayad Azzam, Jamil Nazzal, et al.
Blood|March 27, 2004
Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantationAngela Dispenzieri, Morie A Gertz, Robert A Kyle, et al.
Pageof 76

Showing results (721-730 of 759) with videos related to

Sort By:
Pageof 76
Blood Advances|April 14, 2026
Diagnostic Utility of Immunofixation and Free Light Chain Assay in AL Amyloidosis: A Systematic Review and Meta-analysisMuayad Azzam, Qais Hamarsha, Hassan Kawtharany, et al.
Blood Advances|April 9, 2026
Determinants of Gastrointestinal Disease Burden and Survival in Systemic AL AmyloidosisMaximilian Johannes Steinhardt, Eli Muchtar, Taxiarchis V Kourelis, et al.
Blood Cancer Journal|June 23, 2026
Characteristics and outcomes of secondary hematological malignancies following autologous stem cell transplantation for multiple myelomaBinoy Yohannan, Benjamin W Langworthy, Lindsey E Turner, et al.
Blood|July 8, 2017
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed lenalidomide-refractory multiple myelomaJonas Paludo, Joseph R Mikhael, Betsy R LaPlant, et al.
American Journal of Hematology|January 11, 2021
Comparison of the current renal staging, progression and response criteria to predict renal survival in AL amyloidosis using a Mayo cohortMaria Eleni Drosou, Lisa E Vaughan, Eli Muchtar, et al.
Haematologica|March 5, 2026
Real-world outcomes of newly diagnosed multiple myeloma patients treated with front-line daratumumab bortezomib lenalidomide and dexamethasoneRicardo D Parrondo, Ricardo De Menezes, Hanna Sledge, et al.
Clinical Transplantation|January 8, 2025
Amyloidosis and Heart Transplantation in a New EraMelissa A Lyle, Juan Maria M Farina, Erin Wiedmeier-Nutor, et al.
Mayo Clinic Proceedings|April 2, 2013
Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013Joseph R Mikhael, David Dingli, Vivek Roy, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 1, 2026
The role of cardiac imaging for diagnosis of cardiac amyloidosis: a systematic review and meta-analysis of test accuracyHassan Kawtharany, Muayad Azzam, Jamil Nazzal, et al.
Blood|March 27, 2004
Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantationAngela Dispenzieri, Morie A Gertz, Robert A Kyle, et al.
Pageof 76